China SXT Pharmaceuticals (SXTC) Total Current Liabilities (2018 - 2026)
China SXT Pharmaceuticals' Total Current Liabilities was $4.35 million in fiscal Q4 2026 (quarter ended Mar 31, 2026), down 27.7% from $6.01 million a year earlier.
China SXT Pharmaceuticals (SXTC) Total Current Liabilities (2018 - 2026) Analysis & Trends
From fiscal Q4 2018 onward, China SXT Pharmaceuticals has reported Total Current Liabilities for 17 quarters.
- Total Current Liabilities has now declined for five consecutive fiscal years, with a five-year compound annual growth rate of -25.2% (FY2021 to FY2026).
- In earlier fiscal years, Total Current Liabilities was $6.01 million in FY2025 (-32.5%), $8.9 million in FY2024 (-38.6%), $14.5 million in FY2023 (-15.3%) and $17.12 million in FY2022 (-7.8%).
- The fiscal Q4 2026 figure marks the lowest quarterly Total Current Liabilities since fiscal Q2 2019.
- Compared with a year earlier, Total Current Liabilities was higher in 1 of the last four quarters, with an average decline of 13.0%.
- The best year-over-year quarter for Total Current Liabilities over five years was fiscal Q2 2025 (growth of 70.3%); the worst was fiscal Q2 2026 (a decline of 61.9%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | China SXT Pharmaceuticals | 33,069.96 | -85.92 Mn | - | 4.35 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.35 Mn |
| Sep 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Sep 30, 2024 | 15.66 Mn |
| Mar 31, 2024 | 8.90 Mn |
| Sep 30, 2023 | 9.20 Mn |
| Mar 31, 2023 | 14.50 Mn |
| Sep 30, 2022 | 7.29 Mn |
| Mar 31, 2022 | 17.12 Mn |
| Sep 30, 2021 | 8.88 Mn |
| Mar 31, 2021 | 18.58 Mn |
| Sep 30, 2020 | 5.51 Mn |
| Mar 31, 2020 | 12.26 Mn |
| Sep 30, 2019 | 10.76 Mn |
| Mar 31, 2019 | 6.32 Mn |
| Sep 30, 2018 | 3.99 Mn |
| Mar 31, 2018 | 4.37 Mn |
China SXT Pharmaceuticals Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SXTC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();